Reviews - 1bqt mentioned but not cited (2)
- Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports. Bailes J, Soloviev M. Biomolecules 11 217 (2021)
- Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR-IGF1R hybrid receptor modulators. Turvey SJ, McPhillie MJ, Kearney MT, Muench SP, Simmons KJ, Fishwick CWG. RSC Med Chem 13 360-374 (2022)
Articles - 1bqt mentioned but not cited (3)
- Systematic comparison of crystal and NMR protein structures deposited in the protein data bank. Sikic K, Tomic S, Carugo O. Open Biochem J 4 83-95 (2010)
- Looking at the carcinogenicity of human insulin analogues via the intrinsic disorder prism. Redwan EM, Linjawi MH, Uversky VN. Sci Rep 6 23320 (2016)
- A novel epitope-presenting thermostable scaffold for the development of highly specific insulin-like growth factor-1/2 antibodies. Peeß C, Scholz C, Casagolda D, Düfel H, Gerg M, Kowalewsky F, Bocola M, von Proff L, Goller S, Klöppel-Swarlik H, Hoppe A, Schräml M. J Biol Chem 294 13434-13444 (2019)
Reviews citing this publication (7)
- Molecular interactions of the IGF system. Denley A, Cosgrove LJ, Booker GW, Wallace JC, Forbes BE. Cytokine Growth Factor Rev 16 421-439 (2005)
- Growth factor receptors: structure, mechanism, and drug discovery. McInnes C, Sykes BD. Biopolymers 43 339-366 (1997)
- Transcriptional regulation and biological significance of the insulin like growth factor II gene. Engström W, Shokrai A, Otte K, Granérus M, Gessbo A, Bierke P, Madej A, Sjölund M, Ward A. Cell Prolif 31 173-189 (1998)
- Insulin: a small protein with a long journey. Hua Q. Protein Cell 1 537-551 (2010)
- PAPP-A and the IGF system in atherosclerosis: what's up, what's down? Steffensen LB, Conover CA, Oxvig C. Am J Physiol Heart Circ Physiol 317 H1039-H1049 (2019)
- Theoretical and computational studies of peptides and receptors of the insulin family. Vashisth H. Membranes (Basel) 5 48-83 (2015)
- Insulin-like and mimetic molecules from non-mammalian organisms: potential relevance for drug discovery. Müller GA. Arch Physiol Biochem 126 420-429 (2020)
Articles citing this publication (29)
- Theranostic mesoporous silica nanoparticles biodegrade after pro-survival drug delivery and ultrasound/magnetic resonance imaging of stem cells. Kempen PJ, Greasley S, Parker KA, Campbell JL, Chang HY, Jones JR, Sinclair R, Gambhir SS, Jokerst JV. Theranostics 5 631-642 (2015)
- The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5. Zesławski W, Beisel HG, Kamionka M, Kalus W, Engh RA, Huber R, Lang K, Holak TA. EMBO J 20 3638-3644 (2001)
- Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions. Torres AM, Forbes BE, Aplin SE, Wallace JC, Francis GL, Norton RS. J Mol Biol 248 385-401 (1995)
- Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I. Gauguin L, Delaine C, Alvino CL, McNeil KA, Wallace JC, Forbes BE, De Meyts P. J Biol Chem 283 20821-20829 (2008)
- The folding nucleus of the insulin superfamily: a flexible peptide model foreshadows the native state. Hua QX, Mayer JP, Jia W, Zhang J, Weiss MA. J Biol Chem 281 28131-28142 (2006)
- A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the insulin receptor. Kristensen C, Andersen AS, Hach M, Wiberg FC, Schäffer L, Kjeldsen T. Biochem J 305 ( Pt 3) 981-986 (1995)
- Oxidation of human insulin-like growth factor I in formulation studies: kinetics of methionine oxidation in aqueous solution and in solid state. Fransson J, Florin-Robertsson E, Axelsson K, Nyhlén C. Pharm Res 13 1252-1257 (1996)
- Solution structure of human insulin-like growth factor II; recognition sites for receptors and binding proteins. Terasawa H, Kohda D, Hatanaka H, Nagata K, Higashihashi N, Fujiwara H, Sakano K, Inagaki F. EMBO J 13 5590-5597 (1994)
- A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II. Alvino CL, McNeil KA, Ong SC, Delaine C, Booker GW, Wallace JC, Whittaker J, Forbes BE. J Biol Chem 284 7656-7664 (2009)
- The insulin-like growth factor (IGF)binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysis. Jansson M, Andersson G, Uhlén M, Nilsson B, Kördel J. J Biol Chem 273 24701-24707 (1998)
- Probing the disulfide folding pathway of insulin-like growth factor-I. Milner SJ, Carver JA, Ballard FJ, Francis GL. Biotechnol Bioeng 62 693-703 (1999)
- Aromatic anchor at an invariant hormone-receptor interface: function of insulin residue B24 with application to protein design. Pandyarajan V, Smith BJ, Phillips NB, Whittaker L, Cox GP, Wickramasinghe N, Menting JG, Wan ZL, Whittaker J, Ismail-Beigi F, Lawrence MC, Weiss MA. J Biol Chem 289 34709-34727 (2014)
- Contribution of residue B5 to the folding and function of insulin and IGF-I: constraints and fine-tuning in the evolution of a protein family. Sohma Y, Hua QX, Liu M, Phillips NB, Hu SQ, Whittaker J, Whittaker LJ, Ng A, Roberts CT, Arvan P, Kent SB, Weiss MA. J Biol Chem 285 5040-5055 (2010)
- Unbound (bioavailable) IGF1 enhances somatic growth. Elis S, Wu Y, Courtland HW, Cannata D, Sun H, Beth-On M, Liu C, Jasper H, Domené H, Karabatas L, Guida C, Basta-Pljakic J, Cardoso L, Rosen CJ, Frystyk J, Yakar S. Dis Model Mech 4 649-658 (2011)
- Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties. Milner SJ, Francis GL, Wallace JC, Magee BA, Ballard FJ. Biochem J 308 ( Pt 3) 865-871 (1995)
- Delivering heparin-binding insulin-like growth factor 1 with self-assembling peptide hydrogels. Florine EM, Miller RE, Liebesny PH, Mroszczyk KA, Lee RT, Patwari P, Grodzinsky AJ. Tissue Eng Part A 21 637-646 (2015)
- Solution structure of a mini IGF-1. De Wolf E, Gill R, Geddes S, Pitts J, Wollmer A, Grötzinger J. Protein Sci 5 2193-2202 (1996)
- IGF1 and IGF2 specificities to the two insulin receptor isoforms are determined by insulin receptor amino acid 718. Andersen M, Nørgaard-Pedersen D, Brandt J, Pettersson I, Slaaby R. PLoS One 12 e0178885 (2017)
- Delineation of the IGF-II C domain elements involved in binding and activation of the IR-A, IR-B and IGF-IR. Henderson ST, Brierley GV, Surinya KH, Priebe IK, Catcheside DE, Wallace JC, Forbes BE, Cosgrove LJ. Growth Horm IGF Res 25 20-27 (2015)
- Linkers for improved cleavage of fusion proteins with an engineered alpha-lytic protease. Lien S, Milner SJ, Graham LD, Wallace JC, Francis GL. Biotechnol Bioeng 74 335-343 (2001)
- Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor. Hodgson DR, May FE, Westley BR. Eur J Biochem 233 299-309 (1995)
- Involvement of phenylalanine 23 in the binding of IGF-1 to the insulin and type I IGF receptor. Hodgson DR, May FE, Westley BR. Regul Pept 66 191-196 (1996)
- Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain. Hexnerová R, Křížková K, Fábry M, Sieglová I, Kedrová K, Collinsová M, Ullrichová P, Srb P, Williams C, Crump MP, Tošner Z, Jiráček J, Veverka V, Žáková L. J Biol Chem 291 21234-21245 (2016)
- Signaling Pathways of the Insulin-like Growth Factor Binding Proteins. Baxter RC. Endocr Rev 44 753-778 (2023)
- Design and characterisation of long-R3-insulin-like growth factor-I muteins which show resistance to pepsin digestion. Bryant KJ, Read LC, Forsberg G, Wallace JC. Growth Factors 13 261-272 (1996)
- Secondary structure determination of 15N-labelled human Long-[Arg-3]-insulin-like growth factor 1 by multidimensional NMR spectroscopy. Laajoki LG, Le Breton E, Shooter GK, Wallace JC, Francis GL, Carver JA, Keniry MA. FEBS Lett 420 97-102 (1997)
- Solution structure of a conformationally restricted fully active derivative of the human relaxin-like factor. Büllesbach EE, Hass MA, Jensen MR, Hansen DF, Kristensen SM, Schwabe C, Led JJ. Biochemistry 47 13308-13317 (2008)
- Metabolism and degradation products of recombinant human insulin-like growth factor-I in lysosomes of rat kidney. Tanaka Y, Tamoto H, Tozuka Z, Sato A, Kimura T. Xenobiotica 29 281-295 (1999)
- Non-glycosylated IGF2 prohormones are more mitogenic than native IGF2. Potalitsyn P, Mrázková L, Selicharová I, Tencerová M, Ferenčáková M, Chrudinová M, Turnovská T, Brzozowski AM, Marek A, Kaminský J, Jiráček J, Žáková L. Commun Biol 6 863 (2023)
Related citations provided by authors (1)
- 1H-NMR assignment and secondary structure of human insulin-like growth factor-I (IGF-I) in solution.. Sato A, Nishimura S, Ohkubo T, Kyogoku Y, Koyama S, Kobayashi M, Yasuda T, Kobayashi Y J Biochem 111 529-36 (1992)